Global Microarray Market to Catapult to $7.4 Billion by 2018 NEW YORK, NY -- (Marketwired) -- 08/12/13 -- TriMarkPublications.com cites in its newly published "Microarray Markets" report that the global microarray market will catapult to $7.4 billion by 2018. For more information, visit: http://www.trimarkpublications.com/products/Microarray-Markets.html. Microarrays can be categorized into five main modalities: DNA, protein, tissue, low complexity and carbohydrate. The largest contributor to the microarrays market is the DNA microarrays segment, which is projected to grow at a compound annual growth rate (CAGR) of over 15%. North America is the largest regional microarray market with 40% of the market, followed by Europe, which has 25% of the market, and Asia, which has 18% of the market. The "Microarray Markets" report covers: -- DNA Microarrays -- Protein Microarrays -- Tissue Microarrays -- Low Complexity Microarrays -- Carbohydrate Microarrays -- Forward Phase Microarrays -- Reverse Phase Microarrays -- Peptoid Arrays -- Nucleic Acid Programmable Protein Arrays (NAPPA) -- Antibody Microarrays -- Tiling Arrays -- Epigenetic Mapping Arrays -- Cytokine Arrays -- Whole Proteome Arrays -- Aptamer Arrays -- Cell-Free Arrays -- Protein Nanoarrays -- Lab-on-a-Chip Technologies The "Microarray Markets" report examines companies manufacturing microarray equipment and supplies in the world. Companies covered include: Affymetrix, Agilent, Applied Biosystems/Invitrogen, Applied Microarrays, Arrayit, AutoGenomics, AyoxxA, BioCat, BioChain, BioForce, BioGenex, Biolog, Biomedical, bioMerieux, Biometrix, Bio-Rad, Cancer Genetics, Cepheid, Clontech, CombiMatrix, CYBRDI, DiagnoSwiss, Discerna, EMD Millipore, Eurogentec, Exiqon, Fluidigm, Gamida for Life Group, GE Healthcare, Grace Bio-Labs, Great Basin, Greiner Bio-One, Gyros AB, Healthcare IT, Illumina, Imgenex, Immucor, InDevR, Isu Abxis, LC Sciences, Lineagen, Luminex, Maine Manufacturing, Meso Scale Discovery, Microarrays, Microbionix, Mingyuan Medicare, MiraiBio, Molecular Devices, Monogram, Myriad Genetics, NextGen, One Lambda, OriGene, Orla Protein, Oxford Gene, Oxford Nanopore, PamGene BV, Partek, Pepscan, Perkin Elmer, Phalanx, PharmaSeq, Platypus, Protagen, ProteinOne, ProteoGenix, QIAGEN, R&D Systems, Radix BioSolutions, Randox, RayBiotech, Roche NimbleGen, Sequenom, Sigma-Aldrich, SmartBead, SomaLogic, SQI, SuperBioChips, Theranostic Health, Toray Industries, Trans Genic, US Biomax, Veredus, Zeptosens, Zeus Scientific and Zyagen. Detailed charts with sales forecasts and marketshare data are included. For more information, visit: http://www.trimarkpublications.com/products/Microarray-Markets.html. About TriMarkPublications.com TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit http://www.trimarkpublications.com. Important Notice The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially. Contact TriMarkPublications.com Media Relations 1-888-OK-TRIMARK www.trimarkpublications.com
Global Microarray Market to Catapult to $7.4 Billion by 2018
Press spacebar to pause and continue. Press esc to stop.